Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126007951 | 12600795 | 1 | I | 201606 | 20160617 | 20160727 | 20160727 | PER | US-ASTRAZENECA-2016SE67607 | ASTRAZENECA | 544.00 | MON | Y | 109.80000 | KG | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126007951 | 12600795 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 160720 | MG | 21957 | 40 | MG | QD | ||||||
| 126007951 | 12600795 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 10MCG | 0 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||||
| 126007951 | 12600795 | 3 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 233760 | MG | U | 0 | 40 | MG | TABLET | QD | ||||
| 126007951 | 12600795 | 4 | SS | METOPROLOL. | METOPROLOL | 1 | Oral | 292200 | MG | 0 | 200 | MG | QD | ||||||
| 126007951 | 12600795 | 5 | C | TACOLINUS | 2 | 0 | 1 | MG | |||||||||||
| 126007951 | 12600795 | 6 | C | MYSORTIC | 2 | 0 | 180 | MG | QD | ||||||||||
| 126007951 | 12600795 | 7 | C | PREDNISONE. | PREDNISONE | 1 | 0 | 5 | MG | QD | |||||||||
| 126007951 | 12600795 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | |||||||||
| 126007951 | 12600795 | 9 | C | CALCITROL | CALCITRIOL | 1 | 0 | ||||||||||||
| 126007951 | 12600795 | 10 | C | BYDUREON | EXENATIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126007951 | 12600795 | 1 | Gastrooesophageal reflux disease |
| 126007951 | 12600795 | 2 | Type 2 diabetes mellitus |
| 126007951 | 12600795 | 3 | Hypertension |
| 126007951 | 12600795 | 4 | Hypertension |
| 126007951 | 12600795 | 5 | Renal transplant |
| 126007951 | 12600795 | 6 | Renal transplant |
| 126007951 | 12600795 | 7 | Renal transplant |
| 126007951 | 12600795 | 8 | Type 2 diabetes mellitus |
| 126007951 | 12600795 | 10 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126007951 | 12600795 | Blood glucose decreased | |
| 126007951 | 12600795 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126007951 | 12600795 | 1 | 2005 | 0 | ||
| 126007951 | 12600795 | 2 | 2014 | 20160604 | 0 | |
| 126007951 | 12600795 | 3 | 2000 | 0 | ||
| 126007951 | 12600795 | 4 | 2012 | 0 | ||
| 126007951 | 12600795 | 5 | 2009 | 0 | ||
| 126007951 | 12600795 | 6 | 2009 | 0 | ||
| 126007951 | 12600795 | 7 | 2009 | 0 | ||
| 126007951 | 12600795 | 8 | 2014 | 0 | ||
| 126007951 | 12600795 | 9 | 2015 | 0 |